Van Berkom & Associates Inc. Makes New $3.44 Million Investment in Vital Farms, Inc. $VITL

Key Points

• Van Berkom & Associates bought 107,758 shares of Vital Farms (NASDAQ:VITL) in Q4, a new position valued at about $3.44 million and representing roughly 0.24% of the company.
• Analyst coverage is mixed: the consensus is a Moderate Buy with an average target of $32.42, but several firms have cut targets and ratings (e.g., Needham to $20, DA Davidson to $16) and some downgraded the stock.
• Vital Farms faces mounting litigation risk, with multiple law firms soliciting investors and investigating alleged concealed shelf‑space losses, potentially increasing legal costs and share‑price pressure.

Van Berkom & Associates Inc. bought a new position in Vital Farms, Inc. (NASDAQ:VITL - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 107,758 shares of the company's stock, valued at approximately $3,442,000. Van Berkom & Associates Inc. owned about 0.24% of Vital Farms at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the stock. Truist Financial Corp raised its stake in shares of Vital Farms by 11.9% in the fourth quarter. Truist Financial Corp now owns 20,509 shares of the company's stock worth $655,000 after acquiring an additional 2,189 shares during the last quarter. Hussman Strategic Advisors Inc. raised its stake in shares of Vital Farms by 100.0% in the fourth quarter. Hussman Strategic Advisors Inc. now owns 84,000 shares of the company's stock worth $2,683,000 after acquiring an additional 42,000 shares during the last quarter. Benjamin Edwards Inc. lifted its position in Vital Farms by 13.8% during the 4th quarter. Benjamin Edwards Inc. now owns 10,594 shares of the company's stock valued at $338,000 after purchasing an additional 1,286 shares during the period. New York State Teachers Retirement System acquired a new position in Vital Farms during the 4th quarter valued at about $295,000. Finally, Comerica Bank lifted its position in Vital Farms by 189.0% during the 4th quarter. Comerica Bank now owns 12,219 shares of the company's stock valued at $390,000 after purchasing an additional 7,991 shares during the period. 98.59% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have issued reports on VITL shares. Needham & Company LLC cut their target price on shares of Vital Farms from $35.00 to $20.00 and set a "buy" rating on the stock in a research report on Friday, March 27th. Zacks Research downgraded shares of Vital Farms from a "hold" rating to a "strong sell" rating in a research report on Monday, March 2nd. Weiss Ratings downgraded shares of Vital Farms from a "hold (c)" rating to a "hold (c-)" rating in a research report on Wednesday, April 29th. Stifel Nicolaus cut their target price on shares of Vital Farms from $39.00 to $34.00 and set a "buy" rating on the stock in a research report on Tuesday, April 21st. Finally, Mizuho set a $20.00 target price on shares of Vital Farms in a research report on Monday. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $32.42.

Key Vital Farms News

Here are the key news stories impacting Vital Farms this week:

• Neutral Sentiment: Head-to-head comparison with J.M. Smucker provides peer context but contains no breaking company-specific catalyst; useful for relative valuation/strategy review. J. M. Smucker NYSE: SJM & Vital Farms NASDAQ: VITL Head to Head Comparison
• Negative Sentiment: DA Davidson reaffirmed a "neutral" rating but slashed its price target from $47 to $16, signaling much weaker analyst expectations and likely prompting mark-down selling. Vital Farms' (VITL) "Neutral" Rating Reaffirmed at DA Davidson
• Negative Sentiment: Levi & Korsinsky issued an investor alert alleging Vital Farms concealed shelf-space losses, amplifying legal risk and potential financial/operational disclosure issues. VITL Investor Alert: Vital Farms, Inc. Securities Fraud Lawsuit
• Negative Sentiment: Rosen Law Firm is soliciting Vital Farms investors to secure counsel and join a class action, highlighting coordinated litigation activity and the approaching May 26 lead-plaintiff deadline. ROSEN Encourages Vital Farms Investors to Secure Counsel
• Negative Sentiment: Faruqi & Faruqi and other national firms (Bronstein, Schall, DJS) have issued investor notices and are investigating/pursuing claims, increasing the likelihood of litigation-related costs and management distraction. Faruqi & Faruqi Investor Notice
• Negative Sentiment: PR/firm notices from Schall Law Firm and DJS Law Group reiterate class-period dates and invite lead-plaintiff participation, suggesting broad market outreach that can further pressure the share price. Schall Law Firm Notice

Vital Farms Stock Performance

Vital Farms stock opened at $13.00 on Tuesday. The company has a market cap of $557.05 million, a PE ratio of 9.03 and a beta of 1.20. The company's 50-day moving average is $15.80 and its two-hundred day moving average is $26.10. The company has a current ratio of 2.16, a quick ratio of 1.61 and a debt-to-equity ratio of 0.01. Vital Farms, Inc. has a 1 year low of $11.80 and a 1 year high of $53.13.

Vital Farms (NASDAQ:VITL - Get Free Report) last announced its quarterly earnings results on Thursday, February 26th. The company reported $0.35 earnings per share for the quarter, missing analysts' consensus estimates of $0.38 by ($0.03). The firm had revenue of $213.55 million during the quarter, compared to analyst estimates of $212.83 million. Vital Farms had a net margin of 8.73% and a return on equity of 20.69%. The business's revenue was up 28.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.23 earnings per share. Equities analysts anticipate that Vital Farms, Inc. will post 0.86 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Karl Khoury purchased 5,000 shares of the business's stock in a transaction that occurred on Monday, March 9th. The shares were acquired at an average cost of $18.45 per share, for a total transaction of $92,250.00. Following the transaction, the director directly owned 119,789 shares of the company's stock, valued at approximately $2,210,107.05. The trade was a 4.36% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. Also, major shareholder Matthew Ohayer sold 20,000 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $20.33, for a total transaction of $406,600.00. Following the completion of the sale, the insider owned 6,321,190 shares in the company, valued at $128,509,792.70. This represents a 0.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 21.30% of the company's stock.

About Vital Farms

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms' supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.

Want to see what other hedge funds are holding VITL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vital Farms, Inc. (NASDAQ:VITL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.